EXEL Average Annual Return 10 Years

Growth of $10,000.00
Without Dividends Reinvested Into EXEL

Also see:
• EXEL stock yearly return 2015
• EXEL stock yearly return 2016
• EXEL stock yearly return 2017
• EXEL stock yearly return 2018
• EXEL stock yearly return 2019
• EXEL stock yearly return 2020
• EXEL stock yearly return 2021
• EXEL stock yearly return 2022
• EXEL stock yearly return 2023
• EXEL stock yearly return 2024
• EXEL YTD return

Compare EXEL average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return

Start date:	04/23/2015
End date:	04/22/2025
Start price/share:	$3.10
End price/share:	$36.48
Dividends collected/share:	$0.00
Total return:	1,076.77%
EXEL Average Annual Return:	27.94%
Starting investment:	$10,000.00
Ending investment:	$117,665.68
Years:	10.01

EXEL average annual return is presented with the assumption of reinvestments of any dividends on ex-date.

Exelixis, Inc. is an oncology company. Co. is engaged in developing medicines and combination regimens at the forefront of cancer care. It has produced four marketed pharmaceutical products, two of which are formulations of its flagship molecule, cabozantinib. Cabozantinib is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET and has been also approved as CABOMETYX tablets for advanced renal cell carcinoma (RCC), for previously treated hepatocellular carcinoma (HCC) and for previously treated, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC), and as COMETRIQ capsules for progressive, metastatic medullary thyroid cancer (MTC). The EXEL average annual return 10 years is shown above.

The Average Annual Return on the EXEL average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether EXEL average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the EXEL average annual return calculation with any dividends reinvested as applicable (on ex-dates).

Quotes delayed 20 minutes

Free EXEL Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

10 Most Oversold Stocks in the S&P

10 Most Overbought Stocks in the S&P

10 ETFs With Stocks That Insiders Are Buying

10 ETFs With Most Upside To Analyst Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Energy Stocks You Can Buy Cheaper Than Insiders Did

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active Call & Put Options of the S&P 500 Components

Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Exelixis (EXEL) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

EYE Average Annual Return
EYEG Average Annual Return
EYEN Average Annual Return
EYPT Average Annual Return
FATE Average Annual Return
FBIO Average Annual Return
FBLG Average Annual Return
FBRX Average Annual Return
FDMT Average Annual Return
FEMY Average Annual Return
More Healthcare companies »

★★★★★ Based on a ranking of our entire coverage universe by highest ten year average annual return, Exelixis (EXEL) ranks in the top 25% of all stocks whose returns we have reviewed.

What has the average annual return been for EXEL over the past ten years?

✔️Accepted answer: The ten year EXEL average annual return has been 27.94%.

What start date was used in your EXEL average annual return calculation?

✔️Accepted answer: The start date was 04/23/2015.

What end date was used in your EXEL average annual return calculation?

✔️Accepted answer: The end date was 04/22/2025.

If I had invested $10,000 into EXEL ten years ago, how much would I have today?

✔️Accepted answer: Today, as of 04/22/2025, you would have $117,665.68.

What does that work out to on a total return basis?

✔️Accepted answer: The EXEL ten year total return ending 04/22/2025 works out to 1,076.77%.

EXEL Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2025, All Rights Reserved